Civmec earnings: Profit climbs as $1.4b order book backs FY27 growth
Civmec has delivered FY26 revenue growth of 11.4% and a 22.5% rise in profit, with a $1.4 billion order book supporting its FY27 outlook.
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| BDA | Bod completes first order of medicinal cannabis oil | PRICE SENSITIVE | 12/04/18 | |
| BDA | Symbion to distribute Bod portfolio of natural medicines | PRICE SENSITIVE | 09/04/18 | |
| BDA | API to stock full Bod portfolio of natural medicines | PRICE SENSITIVE | 05/04/18 | |
| BDA | Bod Australia investor evening | 27/03/18 | ||
| BDA | Bod completes import of first cannabis products | PRICE SENSITIVE | 26/03/18 | |
| BDA | Investor Presentation | 02/03/18 | ||
| BDA | Bod delivers strong first half performance | 27/02/18 | ||
| BDA | Half Yearly Report and Accounts | PRICE SENSITIVE | 27/02/18 | |
| BDA | Bods exclusive partner iX Biopharma secures China patent | PRICE SENSITIVE | 26/02/18 | |
| BDA Bod completes first order of medicinal cannabis oil | |||
| 12/04/18 | PRICE SENSITIVE | ||
| BDA Symbion to distribute Bod portfolio of natural medicines | |||
| 09/04/18 | PRICE SENSITIVE | ||
| BDA API to stock full Bod portfolio of natural medicines | |||
| 05/04/18 | PRICE SENSITIVE | ||
| BDA Bod Australia investor evening | |||
| 27/03/18 | |||
| BDA Bod completes import of first cannabis products | |||
| 26/03/18 | PRICE SENSITIVE | ||
| BDA Investor Presentation | |||
| 02/03/18 | |||
| BDA Bod delivers strong first half performance | |||
| 27/02/18 | |||
| BDA Half Yearly Report and Accounts | |||
| 27/02/18 | PRICE SENSITIVE | ||
| BDA Bods exclusive partner iX Biopharma secures China patent | |||
| 26/02/18 | PRICE SENSITIVE | ||
